EM2D9, A monoclonal antibody against integrin α5β1, has potent antitumor activity on endometrial cancer in vitro and in vivo
Year: 2020
Type: article
Source: Cancer Letters
Authors: Yinyan Xu, Yi Li, Jiahui Pan, Xing Kang, Xu Zhang, Xinyi Feng, Shucheng Li, Chengxi Li, Jinku Zhang, Chong Li, Guoqing Wang
Language: English
Subfield: Immunology and Allergy
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Award: G3338471851
OpenAlex ID: W3010438360
